Estimates of promoter methylation obtained for these two tumour suppressor genes (APC and CDKN2A) from both normal colorectal tissue and CRC tumour tissue ranged from zero to >80% and, across this whole range, MS-HRM gave estimates of methylation which were similar to those obtained by pyrosequencing. The gene discussed is CDKN2A; the disease is neoplasm.